Market Research Industry Reports

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in New Zealand. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of New Zealand. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

New Zealand is a mature healthcare market, with a strong regulatory environment. It spends approximately 11% of its GDP on healthcare. In 2015 pharmaceutical sales declined to $688.7m from $796.0m in 2014. This rose to $746.3m in 2016. The market is forecast to grow to $1.03 billion in 2022; at a CAGR of 6%. In 2010, the medical device market in New Zealand was worth $1.17 billion, which increased to $1.48 billion in 2017. The main segments were ophthalmic devices, wound care management, healthcare IT, orthopedic devices and in vitro diagnostics. The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of pharmaceutical market. However, high penetration of generics in the market and the policies of PHARMAC, pose as a barrier for the multinational pharmaceutical manufacturers.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in New Zealand, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Douglas, Mylan, GSK, Merck and NZP) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, DePuy Synthes, Essilor and Fisher & Paykel Healthcare)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of New Zealand
- Porters five forces analysis for pharmaceutical and medical devices market of New Zealand
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the New Zealand healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the New Zealand healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the New Zealand healthcare market.

Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List Of Tables

1.1 List of Tables
Table 1: Pharmaceutical Market, New Zealand, Self medication product groups sales ($m), 2016 20
Table 2: Pharmaceutical Market, New Zealand, Major therapeutic groups based on sales ($m), 2014 21
Table 3: Medical Device Market, New Zealand, Revenue by Segment ($m) and market share (%), 2017 40
Table 4: Ophthalmic Devices Market, New Zealand, Revenue ($m) and Market Share (%) of Major Companies, 2015 41
Table 5: Wound Care Management Market, New Zealand, Revenue ($m) and Market Share (%) of Major Companies, 2017 42
Table 6: Healthcare IT Devices Market, New Zealand, Revenue ($m) and Market Share (%) of Major Companies, 2015 43
Table 7: Orthopedic Devices Market, New Zealand, Revenue ($m) and Market Share (%) of Major Companies, 2016 44
Table 8: IVD Market, New Zealand, Revenue ($m) and Market Share (%) of Major Companies, 2017 45
Table 9: NMA Fees, New Zealand, 2017 81
Table 10: Patent Fees, New Zealand, 2017 85
Table 11: Trademark Fees, New Zealand, 2017 86
Table 12: Clinical Trial Application Fees, New Zealand, 2015 87
Table 13: Pharmacy Regulations, New Zealand, 2011 89
Table 14: Labeling and Packaging Regulations, New Zealand, 2018 90
Table 15: Trade Fairs, New Zealand 101

List Of Figures

1.2 List of Figures
Figure 1: Pharmaceutical Market, New Zealand, Revenue ($m), 2010-2017 8
Figure 2: Medical Device Market, New Zealand, Revenue ($bn), 2010-2017 8
Figure 3: Country Profile, New Zealand, 2018 14
Figure 4: Pharmaceutical Market, New Zealand, Revenue ($m), 2010-2017 16
Figure 5: Pharmaceutical Market, New Zealand, Revenue Forecast ($m), 2018-2022 16
Figure 6: Pharmaceutical Exports ($m), New Zealand, 2010-2017 17
Figure 7: Top Export Partners, New Zealand, 2016 17
Figure 8: Pharmaceutical Imports ($m), New Zealand, 2010-2017 18
Figure 9: Top Import Partners, New Zealand, 2016 18
Figure 10: Distribution Channels, New Zealand, 2016 19
Figure 11: Pharmaceutical Market, New Zealand, Major therapeutic groups based on sales ($m), 2014 21
Figure 12: Pharmaceutical Market, New Zealand, Major Players 23
Figure 13: Medical Device Market, New Zealand, Revenue ($bn), 2010-2017 39
Figure 14: Medical Device Market, New Zealand, Revenue Forecast ($bn), 2018-2022 39
Figure 15: Medical Device Market, New Zealand, Revenue by Segment ($m), 2017 40
Figure 16: Ophthalmic Devices Market, New Zealand, Revenue ($m), 2010-2017 41
Figure 17: Ophthalmic Devices Market, New Zealand, Market Share of Major Players (%), 2015 41
Figure 18: Wound Care Management Market, New Zealand, Revenue ($m), 2010-2017 42
Figure 19: Wound Care Management Market, New Zealand, Market Share of Major Players (%), 2017 42
Figure 20: Healthcare IT Devices Market, New Zealand, Revenue ($m), 2010-2017 43
Figure 21: Healthcare IT Devices Market, New Zealand, Market Share of Major Players (%), 2015 43
Figure 22: Orthopedic Devices Market, New Zealand, Revenue ($m), 2010-2017 44
Figure 23: Orthopedic Devices Market, New Zealand, Market Share of Major Players (%), 2016 44
Figure 24: IVD Market, New Zealand, Revenue ($m), 2010-2017 45
Figure 25: IVD Market, New Zealand, Market Share of Major Companies (%), 2017 45
Figure 26: Diagnostic Market, New Zealand, Revenue ($bn), 2010-2017 46
Figure 27: Diagnostic Market, New Zealand, Revenue ($bn), 2018-2022 46
Figure 28: Medical Device Market, New Zealand, Revenue ($bn) of Major Companies, 2016 48
Figure 29: Deal Value and Deal Count, Pharmaceutical Market, New Zealand, 2017-2018 68
Figure 30: Deal Value and Deal Count Quarterly, Pharmaceutical Market, New Zealand, 2017-2018 68
Figure 31:Deal Value and Deal Count Sub-Types, Pharmaceutical Market, New Zealand, 2017-2018 68
Figure 32: Top 5 therapy area by deal value, Pharmaceutical Market, New Zealand, 2017-2018 69
Figure 33: Top 5 therapy area by deal number, Pharmaceutical Market, New Zealand, 2017-2018 69
Figure 34: M&A deals by therapy area, Pharmaceutical Market, New Zealand, 2017-2018 (By value and by number) 69
Figure 35: Venture Financing deals by therapy area, Pharmaceutical Market, New Zealand, 2017-2018 (By value and by number) 69
Figure 36: Private Equity deals by therapy area, Pharmaceutical Market New Zealand, 2017-2018 (By value and by number) 69
Figure 37: Overview of Healthcare System, New Zealand, 2015 75
Figure 38: Drug Funding/Reimbursement Approval Process , New Zealand, 2013 76
Figure 39: Out-of-Pocket Expenditure (% of total expenditure on health), New Zealand, 2010-2017 78
Figure 40: Change in Health CPI(%), New Zealand , 2009-2016 78
Figure 41: Process of Drug Funding, New Zealand 79
Figure 42: MEDSAFE, Organizational structure, New Zealand, 2015 80
Figure 43: Market Authorization Procedure, New Zealand, 2015 81
Figure 44: WAND Process, New Zealand 82
Figure 45: Licensing Process for Pharmaceutical Manufacturing, New Zealand 83
Figure 46: Patent Approval Process, New Zealand, 2017 85
Figure 47: Trademark Approval Process, New Zealand, 2017 86
Figure 48: Clinical Trial Regulation Process, New Zealand, 2015 87
Figure 49: Pharmaceutical Advertisement Approval Process, New Zealand, 2011 88
Figure 50: Hospitals (Number), New Zealand, 2010-2017 93
Figure 51: Public - Private Hospitals (Number), New Zealand, 2010-2017 93
Figure 52: Diagnostic Equipment (Number), New Zealand, 2010-2017 93
Figure 53: Hospital Beds (per 1,000 population), New Zealand, 2010 - 2017 94
Figure 54: Life Expectancy (years), New Zealand, 2010-2017 94
Figure 55: Immunization Rate (%), New Zealand, 2010-2017 94
Figure 56: Major Causes of Mortality, No. of deaths (000), New Zealand, 2012 95
Figure 57: Major Causes of Male Mortality, No. of deaths (000), New Zealand, 2015 95
Figure 58: Major Causes of Female Mortality, No. of deaths (000), New Zealand, 2015 95
Figure 59: Disability-Adjusted Life Years by Major Disease (000), New Zealand, 2015 95
Figure 60: Physicians (per 1,000 population), New Zealand, 2010-2017 96
Figure 61: Dentists, (per 1,000 population), New Zealand, 2010-2017 96
Figure 62: Nurses (per 1,000 population), New Zealand, 2010-2017 96
Figure 63: Pharmacists, (per 1,000 population), New Zealand, 2010-2017 96
Figure 64: PM2.5 (g per m3), New Zealand, 2010-2017 97
Figure 65: CO2 Emissions (k tons), New Zealand, 2010-2017 97
Figure 66: Healthcare Expenditure (% of GDP ), New Zealand, 2010-2017 98
Figure 67: Public-Private Share (%), New Zealand, 2010-2017 98
Figure 68: Major Components of Healthcare Spending (%), New Zealand, 2011 99
Figure 69: Spending in R&D by sector ($m) , New Zealand, 2008-2016 99
Figure 70: Opportunities and Challenges 103

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New ZealandGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand . The report is

USD 1995View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - BelgiumGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium . The report is an essential

USD 1995View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - BelgiumGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium . The report is an essential

USD 1995View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - DenmarkGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark . The report is an essential

USD 1995View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 1995
  • Site Licence    USD 3990
  • Enterprise Wide Licence    USD 5985
$ 1995

Reports Details

Published Date : Apr 2018
No. of Pages :117
Country :New Zealand
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube